Cardiac Care

PCD Pharma Franchise Opportunities in Meghalaya with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Meghalaya with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as significant health challenges in Meghalaya. According to a systematic review, the prevalence of pre-diabetes in Meghalaya is among the lowest in India at 2.4%. However, diabetes awareness in the state is also the lowest in the country, with only 14.4% of people aware of their condition. This indicates a critical gap in screening and early detection that leaves many patients undiagnosed and untreated. The prevalence of hypertension is also notable. A 2025 study among young adults aged 18-25 years in urban Shillong found that 17.9% had elevated blood pressure. National data indicates that hypertension prevalence among youth in Meghalaya varies from 9.16% at the state level. The Lancet study found that 24.3% of people in Meghalaya suffer from hypertension. The primary drivers include the traditional Meghalaya diet rich in high glycemic index foods like rice, high saturated fat from meat and fish preparations, and sugar-rich sweets combined with sedentary occupations, stressful urban living in cities like Shillong, declining physical activity, high tobacco consumption (52.5% currently), and alcohol use, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The state also has one of the highest cancer rates in India, with 176 cancer cases per one lakh population, further highlighting the burden of non-communicable diseases. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar  it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Meghalaya families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Meghalaya 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Meghalaya patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Meghalaya Daksh works with hospitals, clinics, and pharmacies across Meghalaya to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Meghalaya PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Shillong Cardiac diabetic PCD company in Shillong PCD pharma franchise in Tura Cardiac diabetic products in Tura PCD pharma franchise in Jowai Diabetic cardiac PCD franchise in Jowai PCD pharma franchise in Nongstoin Cardiac diabetic PCD company in Nongstoin PCD pharma franchise in Baghmara Cardiac diabetic products in Baghmara PCD pharma franchise in Williamnagar Diabetic cardiac PCD franchise in Williamnagar PCD pharma franchise in Resubelpara Cardiac diabetic PCD company in Resubelpara PCD pharma franchise in Amlarem Cardiac diabetic products in Amlarem PCD pharma franchise in Mawkyrwat Diabetic cardiac PCD franchise in Mawkyrwat PCD pharma franchise in Mairang Cardiac diabetic PCD company in Mairang Conclusion The diabetes and heart disease burden in Meghalaya is not just a statistic it is a reality affecting thousands of families. With the state recording the lowest diabetes awareness in India at 14.4%, a hypertension prevalence of 24.3%, and high tobacco consumption (52.5%), the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Meghalaya with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Manipur with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Manipur with Daksh Diabetes and Cardiac Care Recent health data reveals that lifestyle diseases, particularly diabetes and hypertension, are emerging as a significant concern in Manipur. Hypertension is the third most important risk factor for non-communicable diseases in the region. A study on the prevalence and risk factors of hypertension among adults in rural areas of Manipur found that prevalence of hypertension among adults was 51.8%, with pre-hypertension prevalence of 30.7%. The study also revealed that 33.5% of the population had never measured their blood pressure, indicating a major gap in awareness and screening that leads to delayed diagnosis. The prevalence of hypertension was higher among females than males across all age groups. The primary drivers include the traditional Manipur diet rich in high glycemic index foods like rice, high saturated fat from meat and fish preparations, and sugar-rich sweets combined with sedentary occupations, stressful urban living, declining physical activity, tobacco use, and alcohol consumption, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The prevalence of generalized obesity and central obesity is also high, which are critical risk factors for the development of diabetes and hypertension. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Manipur families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Manipur 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Manipur patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Manipur Daksh works with hospitals, clinics, and pharmacies across Manipur to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Manipur PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Imphal Cardiac diabetic PCD company in Imphal PCD pharma franchise in Thoubal Cardiac diabetic products in Thoubal PCD pharma franchise in Bishnupur Diabetic cardiac PCD franchise in Bishnupur PCD pharma franchise in Churachandpur Cardiac diabetic PCD company in Churachandpur PCD pharma franchise in Ukhrul Cardiac diabetic products in Ukhrul PCD pharma franchise in Senapati Diabetic cardiac PCD franchise in Senapati PCD pharma franchise in Tamenglong Cardiac diabetic PCD company in Tamenglong PCD pharma franchise in Chandel Cardiac diabetic products in Chandel PCD pharma franchise in Jiribam Diabetic cardiac PCD franchise in Jiribam PCD pharma franchise in Kakching Cardiac diabetic PCD company in Kakching Conclusion The diabetes and heart disease burden in Manipur is not just a statistic it is a reality affecting thousands of families. With a hypertension prevalence of 51.8%, 30.7% in pre-hypertension, and 33.5% never having measured their blood pressure, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Manipur with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Maharashtra with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Maharashtra with Daksh Diabetes and Cardiac Care Recent data from the National Family Health Survey (NFHS-6) 2023-24 reveals that lifestyle diseases, particularly diabetes and hypertension, are escalating rapidly across Maharashtra, with urban centers bearing the brunt of this crisis. The survey shows that 17.7% of men and 16% of women now have high blood sugar levels or are on diabetes medication—a significant jump from 13.6% and 12.4% respectively in NFHS-5 . In urban areas, the prevalence is even higher, with 20.4% of men and 19.3% of women affected, meaning nearly one in five urban adults is living with diabetes. The burden of hypertension is equally alarming. Overall, 27.7% of men and 24.9% of women have elevated blood pressure or are on medication. Among urban men, the figure touches 30% —nearly one in three men in Maharashtra’s cities is living with hypertension, while urban women record a prevalence of 26%. The NFHS-5 survey had already established Maharashtra’s diabetes prevalence at 13%, with urban areas showing 15% prevalence. District-level analysis from NFHS-5 revealed that Sindhudurg had the highest prevalence at 23.4% among men and 20.6% among women, followed by Mumbai Suburban (21% men, 19.7% women). The state also has a concerning prevalence of abdominal obesity—51.5% of urban women and 43.2% of urban men have increased waist-hip ratio, a key risk factor for diabetes and heart disease . The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Maharashtra families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Maharashtra 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Maharashtra patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Maharashtra Daksh works with hospitals, clinics, and pharmacies across Maharashtra to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The PCD pharma market in Maharashtra offers low investment (starting at approximately ₹25,000) with high profit margins and monopoly rights in selected areas. Popular Locations for PCD Pharma Franchise in Maharashtra PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Mumbai Cardiac diabetic PCD company in Mumbai PCD pharma franchise in Pune Cardiac diabetic products in Pune PCD pharma franchise in Nagpur Diabetic cardiac PCD franchise in Nagpur PCD pharma franchise in Nashik Cardiac diabetic PCD company in Nashik PCD pharma franchise in Aurangabad Cardiac diabetic products in Aurangabad PCD pharma franchise in Thane Diabetic cardiac PCD franchise in Thane PCD pharma franchise in Kolhapur Cardiac diabetic PCD company in Kolhapur PCD pharma franchise in Solapur Cardiac diabetic products in Solapur PCD pharma franchise in Dhule Diabetic cardiac PCD franchise in Dhule PCD pharma franchise in Jalgaon Cardiac diabetic PCD company in Jalgaon Conclusion The diabetes and heart disease epidemic in Maharashtra is not just a statistic—it is a reality affecting millions of families. With the state recording a diabetes prevalence of 17.7% among men and 16% among women, hypertension affecting 30% of urban men, and the highest number of US FDA-approved pharma plants in India, the burden and the opportunity are both immense. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Maharashtra with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Madhya Pradesh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Madhya Pradesh with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Madhya Pradesh, affecting both urban and rural populations. The National Family Health Survey (NFHS-5) found that the prevalence of diabetes in Madhya Pradesh is 7.3%. A 2025 study in rural Madhya Pradesh found 5.1% of participants with diabetes, while a study among urban slum dwellers in Bhopal found a high burden of non-communicable diseases with significant gender disparities. The burden of hypertension is even more alarming. NFHS-5 data shows 11.4% of women and 14.9% of men aged 15 and above have hypertension. A 2026 study in rural MP found a hypertension prevalence of 27.6%. The 2023-24 National Non-Communicable Disease Monitoring Survey found that Madhya Pradesh had the highest prevalence of hypertension among the states surveyed, with rates as high as 36.3% in some districts . The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Madhya Pradesh families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Madhya Pradesh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Madhya Pradesh patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Madhya Pradesh Daksh works with hospitals, clinics, and pharmacies across Madhya Pradesh to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Madhya Pradesh PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Bhopal Cardiac diabetic PCD company in Bhopal PCD pharma franchise in Indore Cardiac diabetic products in Indore PCD pharma franchise in Jabalpur Diabetic cardiac PCD franchise in Jabalpur PCD pharma franchise in Gwalior Cardiac diabetic PCD company in Gwalior PCD pharma franchise in Ujjain Cardiac diabetic products in Ujjain PCD pharma franchise in Sagar Diabetic cardiac PCD franchise in Sagar PCD pharma franchise in Dewas Cardiac diabetic PCD company in Dewas PCD pharma franchise in Satna Cardiac diabetic products in Satna PCD pharma franchise in Ratlam Diabetic cardiac PCD franchise in Ratlam PCD pharma franchise in Rewa Cardiac diabetic PCD company in Rewa Conclusion The diabetes and heart disease epidemic in Madhya Pradesh is not just a statistic it is a reality affecting thousands of families. With a diabetes prevalence of 7.3%, hypertension affecting up to 36.3% in some districts, and significant undiagnosed cases, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Madhya Pradesh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Kerala with Daksh Diabetes and Cardiac Care

Uncategorized /

PCD Pharma Franchise Opportunities in Kerala with Daksh Diabetes and Cardiac Care Recent data reveals that Kerala has become India’s diabetes capital, with prevalence more than double the national average. According to the National Family Health Survey (NFHS-6) 2023-24, 31.9% of men and 28.9% of women in Kerala have high blood sugar levels or are on diabetes medication. This marks a sharp rise from 27.0% and 24.8% respectively in NFHS-5. The state leads the country in diabetes prevalence, with nearly one in three adult men now affected. The burden of hypertension is equally concerning. NFHS-6 data shows 31.9% of women and 36.6% of men have elevated blood pressure or are on medication. A spatial analysis of South India found Kerala exhibiting the highest hypertension prevalence, with significant clustering of cases across districts. A community-based study in Northern Kerala found a diabetes prevalence of 30% and an impaired glucose tolerance prevalence of 47.4%, indicating that nearly half the population is at high risk of developing diabetes. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Kerala families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Kerala 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Kerala patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Goa Daksh works with hospitals, clinics, and pharmacies across Kerala to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Goa PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Thiruvananthapuram Cardiac diabetic PCD company in Thiruvananthapuram PCD pharma franchise in Kochi Cardiac diabetic products in Kochi PCD pharma franchise in Kozhikode Diabetic cardiac PCD franchise in Kozhikode PCD pharma franchise in Thrissur Cardiac diabetic PCD company in Thrissur PCD pharma franchise in Kollam Cardiac diabetic products in Kollam PCD pharma franchise in Kannur Diabetic cardiac PCD franchise in Kannur PCD pharma franchise in Alappuzha Cardiac diabetic PCD company in Alappuzha PCD pharma franchise in Palakkad Cardiac diabetic products in Palakkad PCD pharma franchise in Malappuram Diabetic cardiac PCD franchise in Malappuram PCD pharma franchise in Kasaragod Cardiac diabetic PCD company in Kasaragod Conclusion The diabetes and heart disease epidemic in Kerala is not just a statistic—it is a reality affecting millions of families. With the state recording the highest diabetes prevalence in India at 31.9% among men and 28.9% among women, and hypertension affecting over 36% of men, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Kerala with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Karnataka with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Karnataka with Daksh Diabetes and Cardiac Care Recent health data paints a concerning picture of Karnataka’s escalating diabetes and hypertension crisis. According to the National Family Health Survey (NFHS-5), the prevalence of diabetes in Karnataka is 8.4%, higher than the national average of 7.3%. However, more localized studies reveal even more alarming figures—a community-based study in rural Dakshina Kannada found a diabetes prevalence of 31.4%, with 63.5% unaware of their condition and only 52.1% of those treated achieving adequate blood sugar control. The state’s hypertension burden is equally severe, with 25% of women and 26.9% of men aged 15 and above having hypertension, exceeding the national averages of 21.3% and 24% respectively. A rural Bengaluru study found a diabetes prevalence of 10.9%, a prediabetes prevalence of 6.3%, and hypertension prevalence of 24.3%, with more than one-third of diabetics and three-fourths of hypertensives being newly diagnosed during screening. Karnataka has emerged as a focal point for non-communicable diseases, with 10.6% of the population now living with diabetes and a further 13.7% in the pre-diabetic stage, along with 31.5% affected by high blood pressure. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Karnataka families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Karnataka 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Karnataka patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Karnataka Daksh works with hospitals, clinics, and pharmacies across Karnataka to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Karnataka PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Bengaluru Cardiac diabetic PCD company in Bengaluru PCD pharma franchise in Mysuru Cardiac diabetic products in Mysuru PCD pharma franchise in Hubballi Diabetic cardiac PCD franchise in Hubballi PCD pharma franchise in Mangaluru Cardiac diabetic PCD company in Mangaluru PCD pharma franchise in Belagavi Cardiac diabetic products in Belagavi PCD pharma franchise in Kalaburagi Diabetic cardiac PCD franchise in Kalaburagi PCD pharma franchise in Davanagere Cardiac diabetic PCD company in Davanagere PCD pharma franchise in Ballari Cardiac diabetic products in Ballari PCD pharma franchise in Tumakuru Diabetic cardiac PCD franchise in Tumakuru PCD pharma franchise in Shivamogga Cardiac diabetic PCD company in Shivamogga Conclusion The diabetes and heart disease epidemic in Karnataka is not just a statistic—it is a reality affecting millions of families. With the state recording a diabetes prevalence of 8.4%, rural rates as high as 31.4%, and hypertension affecting 31.5%, the burden is already immense and growing. The high rates of undiagnosed disease and inadequate control create a pressing need for quality, accessible medications. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Karnataka with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Jharkhand with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Jharkhand with Daksh Diabetes and Cardiac Care Recent data from the Indian Council of Medical Research (ICMR) reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Jharkhand, affecting both rural and tribal populations. The ICMR-INDIAB study found that the prevalence of diabetes in Jharkhand is 6.32%, with a significant urban-rural divide—13% in urban areas compared to just 3% in rural areas. A 2022-2023 community-based study in rural Jharkhand found an even higher diabetes prevalence of 16.3%. The burden of hypertension is equally alarming. NFHS-5 data shows that 17.8% of women and 22.6% of men aged 15 and above have hypertension. A 2023 hospital-based study in Jharkhand found that 33.4% of patients visiting a cardiac OPD had hypertension, with 40.1% demonstrating inadequate knowledge about the condition. A 2026 study among the primitive Sabar tribe in East Singhbhum found a hypertension prevalence of 19.9%. Among older adults in Deoghar district, 42.3% were hypertensive and 19.9% were diabetic. Tribal communities, traditionally considered low-risk, are now experiencing rising rates due to lifestyle shifts, with 19.9% of the Sabar tribe hypertensive and 38.4% overweight or obese. A 2024-25 Jharkhand-based study found metabolic syndrome prevalence at 10%, with men nearly twice as likely to be obese compared to women. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Jharkhand families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Jharkhand 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Jharkhand patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Jharkhand Daksh works with hospitals, clinics, and pharmacies across Jharkhand to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Jharkhand PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Ranchi Cardiac diabetic PCD company in Ranchi PCD pharma franchise in Jamshedpur Cardiac diabetic products in Jamshedpur PCD pharma franchise in Dhanbad Diabetic cardiac PCD franchise in Dhanbad PCD pharma franchise in Bokaro Cardiac diabetic PCD company in Bokaro PCD pharma franchise in Hazaribagh Cardiac diabetic products in Hazaribagh PCD pharma franchise in Deoghar Diabetic cardiac PCD franchise in Deoghar PCD pharma franchise in Giridih Cardiac diabetic PCD company in Giridih PCD pharma franchise in Dumka Cardiac diabetic products in Dumka PCD pharma franchise in Palamu Diabetic cardiac PCD franchise in Palamu PCD pharma franchise in Simdega Cardiac diabetic PCD company in Simdega Conclusion The diabetes and heart disease epidemic in Jharkhand is not just a statistic—it is a reality affecting thousands of families. With a diabetes prevalence of 6.32%, hypertension affecting 33.4% of OPD patients, and tribal populations showing rates as high as 19.9%, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Jharkhand with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Himachal Pradesh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Himachal Pradesh with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Himachal Pradesh. According to the Longitudinal Ageing Study in India (LASI 2017-18), 11.4% of men and 12.2% of women aged 45 and above have diabetes. The National Family Health Survey (NFHS-5) found that the diabetes prevalence in Himachal Pradesh is higher than the national average, with rates significantly elevated in urban areas. The burden of hypertension is equally alarming. An ICMR study found that 16.7% of the population in Himachal Pradesh has raised blood pressure, with 35.3% in the pre-hypertension stage. This indicates a massive at-risk population that is on the verge of developing full-blown hypertension. The primary drivers include the traditional Himachali diet—rich in high glycemic index foods like rice and wheat, high saturated fat from ghee and butter, and sugar-rich sweets—combined with sedentary occupations, stressful urban living in cities like Shimla, Solan, and Mandi, declining physical activity, and increased consumption of processed foods. A recent national survey found that 69% of households in Punjab, Haryana, and Himachal have members addicted to sugar or sugary products, making it the single biggest contributor to the diabetes epidemic. Additionally, fatty liver cases in Himachal Pradesh have increased by 40% in the last six months, with doctors attributing this to junk food and spicy food consumption, affecting even 10-year-old children. The state also has a high prevalence of hidden diabetes, with many cases going undiagnosed. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Himachal families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Himachal Pradesh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Himachal patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Himachal Pradesh Daksh works with hospitals, clinics, and pharmacies across Himachal Pradesh to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The pharma market in Himachal offers low investment (starting at ₹25,000) with high profit margins and monopoly rights in selected areas. Popular Locations for PCD Pharma Franchise in Himachal Pradesh PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Baddi Cardiac diabetic PCD company in Baddi PCD pharma franchise in Solan Cardiac diabetic products in Solan PCD pharma franchise in Paonta Sahib Diabetic cardiac PCD franchise in Paonta Sahib PCD pharma franchise in Shimla Cardiac diabetic PCD company in Shimla PCD pharma franchise in Mandi Cardiac diabetic products in Mandi PCD pharma franchise in Kangra Diabetic cardiac PCD franchise in Kangra PCD pharma franchise in Una Cardiac diabetic PCD company in Una PCD pharma franchise in Hamirpur Cardiac diabetic products in Hamirpur PCD pharma franchise in Kullu Diabetic cardiac PCD franchise in Kullu PCD pharma franchise in Chamba Cardiac diabetic PCD company in Chamba Conclusion The diabetes and heart disease epidemic in Himachal Pradesh is not just a statistic—it is a reality affecting thousands of families. With the state recording a diabetes prevalence of 11.4% among men and 12.2% among women aged 45+ , pre-hypertension affecting 35.3% , and 40% increase in fatty liver cases, the burden is already immense and growing . But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Himachal Pradesh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Haryana with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Haryana with Daksh Diabetes and Cardiac Care Recent data from the Ministry of Health and Family Welfare’s National Family Health Survey-6 (2023-24) reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Haryana. The survey shows that high or very high blood sugar affects 16.7% of women and 18.5% of men, up significantly from 11.9% and 13.5% respectively in NFHS-5. Urban men record 19.8% and rural men 17.7%, indicating the gap between city and village is narrowing rapidly. Even more concerning, 33.2% of women and 33.9% of men in Haryana are now overweight or obese, rising to 44.0% among urban women – both figures substantially higher than NFHS-5. A community-based study in rural Haryana found that overweight and obesity were the strongest risk factors for diabetes, with nearly a sixfold increase in odds (OR: 5.80). The prevalence of newly detected diabetes in this rural population was 6.2%, with adults aged 50-59 years being at 3.4 times higher risk. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Haryana families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Haryana 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Haryana patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Haryana Daksh works with hospitals, clinics, and pharmacies across Haryana to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and strategic location—Haryana is actively transforming into a globally competitive healthcare manufacturing hub through its Pharmaceutical and Medical Devices Manufacturing Policy 2026, targeting over ₹10,000 crore in investments and 20,000 new jobs—there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Haryana PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Panchkula Cardiac diabetic PCD company in Panchkula PCD pharma franchise in Chandigarh Cardiac diabetic PCD company in Chandigarh PCD pharma franchise in Gurugram Cardiac diabetic products in Gurugram PCD pharma franchise in Faridabad Diabetic cardiac PCD franchise in Faridabad PCD pharma company in Ambala Cardiac diabetic PCD franchise in Ambala PCD franchise in Hisar Cardiac diabetic products in Hisar PCD pharma franchise in Karnal Diabetic cardiac PCD company in Karnal PCD pharma franchise in Kurukshetra Cardiac diabetic PCD franchise in Kurukshetra PCD franchise company in Rohtak Cardiac diabetic medicines in Rohtak PCD pharma in Yamunanagar Diabetic cardiac care in Yamunanagar Conclusion The diabetes and heart disease epidemic in Haryana is not just a statistic – it is a reality affecting millions of families. Many individuals are silently struggling with these conditions, often unaware of their impact on long-term health. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Haryana with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Gujarat with Daksh Diabetes and Cardiac Care

Uncategorized /

PCD Pharma Franchise Opportunities in Gujarat with Daksh Diabetes and Cardiac Care Recent data from the National Family Health Survey (NFHS-6) for 2023-24 reveals that lifestyle diseases, particularly diabetes and hypertension, are rising at an alarming pace across Gujarat. The state now records 18.6% of men and 16.4% of women with high blood sugar levels, while hypertension affects 22.3% of men and 20.9% of women. Perhaps most concerning, one in three Gujarati adults is now overweight or obese—women’s obesity jumped from 22.7% to 32.1% and men’s from 20.0% to 29.9% in just four years. According to the Global Burden of Disease study, diabetes prevalence in Gujarat increased at a rate of 0.67% per year between 1990 and 2021—from 157 to 262 individuals per 1 lakh population—placing the state among the top seven with the highest increase. The average age of diabetes diagnosis has dropped from the late 40s to the early 30s, making early-onset diabetes a growing crisis. The state has also seen a sharp rise in pre-diabetes, with 13.2% of the population in the pre-diabetic stage. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Gujarat families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Gujarat 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Gujarat patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Gujarat Daksh works with hospitals, clinics, and pharmacies across Gujarat to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The pharma market in Gujarat offers low investment with high profit margins and monopoly rights in selected areas. Popular Locations for PCD Pharma Franchise in Gujarat PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Ahmedabad Cardiac diabetic PCD company in Ahmedabad PCD pharma franchise in Surat Cardiac diabetic products in Surat PCD pharma franchise in Vadodara Diabetic cardiac PCD franchise in Vadodara PCD pharma franchise in Rajkot Cardiac diabetic PCD company in Rajkot PCD pharma franchise in Bhavnagar Cardiac diabetic products in Bhavnagar PCD pharma franchise in Jamnagar Diabetic cardiac PCD franchise in Jamnagar PCD pharma franchise in Junagadh Cardiac diabetic PCD company in Junagadh PCD pharma franchise in Gandhinagar Cardiac diabetic products in Gandhinagar PCD pharma franchise in Anand Diabetic cardiac PCD franchise in Anand PCD pharma franchise in Nadiad Cardiac diabetic PCD company in Nadiad Conclusion The diabetes and heart disease epidemic in Gujarat is not just a statistic—it is a reality affecting millions of families. With the state recording the highest edible oil consumption in India, obesity rates exceeding 32%, and early-onset diabetes dropping to the 30s, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Gujarat with Daksh Diabetes and Cardiac Care Read More »